sb 203580 has been researched along with chitosan in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 27,648 | 232 | 21,257 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; He, B; Li, X; Liu, S; Pan, F; Tao, H; Wei, A | 1 |
1 other study(ies) available for sb 203580 and chitosan
Article | Year |
---|---|
Carboxymethylated chitosan protects rat chondrocytes from NO‑induced apoptosis via inhibition of the p38/MAPK signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Proliferation; Cell Survival; Chitosan; Chondrocytes; Cytoprotection; Enzyme Activation; Imidazoles; MAP Kinase Signaling System; Nitric Oxide; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats, Sprague-Dawley; RNA, Messenger | 2016 |